首页> 外文期刊>Indian journal of dermatology >A META-ANALYSIS COMPARING EFFICACY OF CONTINUOUS TERBINAFINE WITH INTERMITTENT ITRACONAZOLE FOR TOENAIL ONYCHOMYCOSIS
【24h】

A META-ANALYSIS COMPARING EFFICACY OF CONTINUOUS TERBINAFINE WITH INTERMITTENT ITRACONAZOLE FOR TOENAIL ONYCHOMYCOSIS

机译:连续特比萘芬与间断伊曲康唑治疗趾甲真菌病的meta分析比较

获取原文
           

摘要

Background:Toenail onychomycosis is a challenge for clinicians to treat. While both Itraconazole and terbinafine have proven to be effective against onychomycosis, very little is known about their comparative efficacy in achieving mycological and clinical cure.Aim:The purpose of this meta-analysis is to compare the efficacy of continuous terbinafine with intermittent itraconazole in the treatment of toenail onychomycosis.Material and Methods:all RCTs comparing continuous terbinafine with intermittent itraconazole were identified from PUBMED and BIDS electronic database.Results:analysis of total eight trials including 1181 patients state that treatment with continuous terbinafine is more likely to produce mycological and clinical cure compared to intermittent itraconazole with odds ratio 2.3(95% CI, 1.7 to 3.0 P<0.0001)Conclusion:though both itraconazole and terbinafine are well tolerated and highly effective drugs, continuous terbinafine is more effective than intermittent itraconazole at achieving mycological cure of toenail onychomycosis
机译:背景:趾甲甲癣对临床医生来说是一个挑战。虽然伊曲康唑和特比萘芬均被证明对甲癣有效,但关于它们在实现真菌学和临床治愈方面的相对功效知之甚少。目的:本荟萃分析的目的是比较连续特比萘芬与间断伊曲康唑在治疗中的疗效。材料与方法:从PUBMED和BIDS电子数据库中鉴定出了将连续特比萘芬与间断伊曲康唑进行比较的所有RCT。结果:对包括1181例患者在内的总共8项试验的分析表明,连续使用特比萘芬治疗更可能产生真菌学和临床意义与间歇性伊曲康唑相比治愈率比为2.3(95%CI,1.7至3.0 P <0.0001)结论:尽管伊曲康唑和特比萘芬均具有良好的耐受性和高效药物,但连续的特比萘芬比间歇性伊曲康唑在实现趾甲的真菌学治愈方面更有效灰指甲病

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号